Unlike Laboratory and PCR tests, ASSURE tests deliver results in just a few minutes and can be done anywhere. The simple test requires no special processing, no waiting, and no advanced equipment. Rapid, regular infectiousness tests can enable a safer reopening for schools and the economy.
Rapid, regular, and affordable infectiousness tests for COVID-19 will enable a safer reopening.
Regular, rapid, and affordable COVID-19 testing will make it possible to identify and isolate infected students more quickly. ASSURE tests could help slow the virus' spread by enabling all at-risk students, including pre- or asymptomatic ones, to be detected and effectively quarantined. Research shows that if done properly, rapid and regular testing protocols could drive down infections close to zero.
In the workplace, ASSURE tests could prevent 88% of viral transmissions if repeated regularly (twice a week) and with isolation of those who test positive, according to research published by Dr. Daniel Larremore, an applied mathematician who models infectious diseases at the University of Colorado, Boulder.
ASSURE tests could enable airports to safely reopen, testing both departing and arriving passengers, with follow-up testing for several days following travel. This would allow tourism industries to reopen for business while protecting both visitors and airport & hospitality staff.
There are many existing tests and many more that are being rapidly developed and deployed in the global fight against the SARS-CoV-2 pandemic.
ASSURE rapid tests do not require a laboratory with special equipment, or lengthy waits for results. The test is simple and can deliver results within minutes.
PCR testing is the current gold standard for detecting COVID-19 infection, but requires a lab with specialized equipment to amplify genetic material, which can take days to return results.
'Loop-mediated Isothermal Amplification' testing is performed by medical professionals that must have expensive special equipment, and wait times are measured in hours.
Oceanit Laboratories has partnered with researchers, physicians, and academics from The University of Hawaii and The Queen's Medical Center to drive ASSURE rapid tests forward, from 'Mind to Market'
Oceanit has teamed with researchers at the John A. Burns School of Medicine (JABSOM) at the University of Hawai‘i at Mānoa, one of the leading medical education institutions in the United States. For the last three years, JABSOM has ranked #1 in National Institutes of Health research awards among community-based public medical schools.
Oceanit is a ‘Mind to Market’ company that employs a unique discipline called Intellectual Anarchy to move fundamental scientific breakthroughs from the lab to the market. Oceanit’s teams deliver cutting-edge solutions, services, and products to customers across a vast range of industries.
The Queen's Medical Center is a nonprofit hospital with a 160-year legacy of caring for the people of Hawaii and the Pacific Basin. A member of The Queen’s Health Systems family of hospitals, The Queen’s Medical Center is the largest private hospital in Hawaii.
Frequently asked questions to help you learn more about ASSURE rapid tests.
ASSURE tests are not yet available to the public. Currently, all ASSURE manufactured tests are being used in clinical trials. Following clinical testing and FDA Emergency Use Authorization (EUA), tests will be made available through a variety of distribution partners, including drug stores and health centers.
ASSURE is not yet available for public purchase. After receiving FDA Emergency Use Authorization, the cost is expected to quickly drop below $10/test as production scales up. Our goal is to make ASSURE tests so affordable that anybody can affordably access multiple tests – no matter where they are or what their current financial condition may be.
ASSURE tests use swabbed specimens to detect COVID-19 using a test cassette, similar to a home pregnancy test. ASSURE-100 uses a shallow nasal swab specimen that is mixed with buffer solution. This mixture is then dropped on the test cassette. ASSURE-19 uses a saliva swab specimen that is mixed with buffer solution. This mixture is then dropped on the test cassette. ASSURE tests have two lines – one to show that the test is working properly (control), and a second line that indicates a positive result is SARS-CoV-2 virus is detected.
ASSURE is estimated to have 97% specificity (true positive rate) and is sensitive enough to detect COVID-19 as viral levels are approaching infectiousness states. The key to managing the pandemic is to inform asymptomatic or pre-symptomatic persons who would otherwise unwittingly infect their friends, family or co-workers.
A positive result can be read on ASSURE in as little as 5 minutes. It is recommended that you wait up to 20 minutes to confirm a negative result. Results should not be read after 30 minutes.
While many rapid COVID-19 tests are being developed, ASSURE uses specifically designed molecules to seek out and lock onto proteins in the SARS-CoV-2 virus. ASSURE works without special equipment, with no refrigeration, and without other complicated steps, like mailing samples. The test cassette acts like a pregnancy test: once the specimen is mixed and applied, simply wait for a result (visible red line) to appear.
Do you have questions that aren’t answered here? Please click below to contact Oceanit and submit your question.
Founded in 1985 in Honolulu, Hawaii, Oceanit has earned a world-class reputation for breakthrough science & technology, sustainable engineering, and disruptive innovation built upon our values of Curiosity, Community, and Ohana. We are a skilled group of scientists, engineers, innovators, and entrepreneurs who solve the world’s most difficult problems.
If you have any other questions, please contact Oceanit by clicking the button below and emailing us. Alternatively, you can get in touch by filling the contact form, here.